Is Patrys Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Patrys Ltd (PAB.AX) is currently classified as HALAL as of July 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Patrys Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Patrys Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Patrys Ltd?

Muslim investors may consider investing in Patrys Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Patrys Ltd classified as HALAL?

Musaffa determines the Shariah status of Patrys Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Patrys Ltd updated?

The Shariah compliance status of Patrys Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Patrys Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Patrys Ltd?

You can check the latest Shariah compliance status of Patrys Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

PAB.AX Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: July 31, 2025

Report Source: 2025 2nd Quarter Report

Patrys Ltd. Stock Analysis PAB.AX

Australia Health Care Nano Cap Report: Q2, 2025

Patrys Ltd. engages in the commercialization of the group's proprietary technologies to develop natural human antibody-based therapeutic products for the treatment of cancer and the pursuit of non-dilutive funding sources. The company is headquartered in South Melbourne, Victoria. The company went IPO on 2007-07-13. The firm is focused on the development of its deoxymab platform of cell-penetrating antibodies as therapies for a range of different indications. The Company’s deoxymab platform is based on the deoxymab 3E10 antibody that is identified as an autoantibody in a mouse model of the human disease systemic lupus erythematosus (SLE). The company has developed two humanized forms of deoxymab 3E10, called PAT-DX1 and PAT-DX3, which have improved activity over the original 3E10 antibody. PAT-DX1 is a dimer of a small antibody fragment derived from a humanized version of the binding domain from the original mouse deoxymab antibody 3E10. PAT-DX3 is a humanized, full-sized antibody that has been further optimized to improve its therapeutic potential. The company is also focused on developing RLS-2201, a proprietary injectable formulation of quetiapine.

Key Statistics of Patrys Ltd (PAB.AX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

AUD0.03AUD0.03

Today's Open

AUD0.03

Volume

477.25K

P/E Ratio (TTM)

52 Week Range

AUD0.01AUD0.05

Market Cap

20.00M

Avg. Volume

718.66K

Dividend Yield

Financial Metrics & Statements of Patrys Ltd (PAB.AX)

FAQ's for Patrys Ltd (PAB.AX)

According to Musaffa’s Shariah screening methodology, Patrys Ltd (PAB.AX) is currently classified as HALAL as of July 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.